tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed

From 2022 to 2025, CEO pay as reported rose 22% while net income rose 28%. $100 in the shares at the start of the table was worth $152 at the end (peer group: $189). CEO pay over the 5 years: $125.3M.

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) Other executives, average$100 becamePeer groupNet income Annual relative total shareholder return
Dec 28, 2025J. Duato $32.8M$68.3M $12.5M $152$189 $26.8B 0.245
Dec 29, 2024J. Duato $24.3M$17.0M $11.2M $103$148 $14.1B -0.199
Dec 31, 2023J. Duato $28.4M$13.8M $12.5M $108$137 $35.2B -0.186
Jan 1, 2023J. Duato $13.1M$18.9M $8.0M $118$137 $17.9B 0.056
Jan 2, 2022A. Gorsky $26.7M$39.4M $12.5M $111$126 $20.9B -0.024

Pay versus performance table of the proxy statement (DEF 14A) filed Mar 11, 2026, as tagged by the company in XBRL. Open the proxy ↗

Next Crypto holdings →

Work on JNJ in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JNJ/export.csv") into a cell.